Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025, at the registered office in Vadodada. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025. No specific financial figures, guidance, or projections have been disclosed in this intimation — only the meeting schedule. The trading window for designated persons is already closed since October 1, 2025, and will reopen 48 hours after the results are declared.
This is a routine regulatory intimation ahead of the Q2 FY26 earnings announcement. Shareholders should watch for the actual results on or after November 12 for any meaningful impact on the stock; this filing itself is neutral.